Literature DB >> 2922064

[The decision making process of the family physician in choosing a drug].

B Wierenga, S J Jong, A F Mantel.   

Abstract

The GP's decision-making process in selecting drugs, as determined empirically, is described. In most cases (approx. 90%), the GP depends on ready memory and chooses from among 4-5 drugs that come to mind first. The cognitive structure of the storage of drugs in the GP's memory is primarily determined by the chemical properties and action. Proprietary drugs constitute the nodes of this cognitive structure. Criteria involved beside those mentioned above are price, efficacy and Dutch make. Prescription preferences are primarily determined by side effects and efficacy, much less by price and product type (proprietary vs generic drugs). Analysis of the GP's decision-making process using general models of human decision making and consumer behaviour is a promising technique for further study of doctors' selection of drugs.

Entities:  

Mesh:

Year:  1989        PMID: 2922064

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  4 in total

1.  Drugs prescribed by general practitioners.

Authors: 
Journal:  Occas Pap R Coll Gen Pract       Date:  1991-11

Review 2.  The System of Objectified Judgement Analysis (SOJA). A tool in rational drug selection for formulary inclusion.

Authors:  R Janknegt; A Steenhoek
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

3.  Do decision support systems influence variation in prescription?

Authors:  Judith D de Jong; Peter P Groenewegen; Peter Spreeuwenberg; Gert P Westert; Dinny H de Bakker
Journal:  BMC Health Serv Res       Date:  2009-01-30       Impact factor: 2.655

4.  Do medical students copy the drug treatment choices of their teachers or do they think for themselves?

Authors:  J Tichelaar; M C Richir; H J Avis; H J Scholten; N F Antonini; Th P G M De Vries
Journal:  Eur J Clin Pharmacol       Date:  2009-11-24       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.